- NEW YORK (Reuters) - The
Defense Department is pressing for the approval of a new drug that could
help against radiation amid worries that Osama bin Laden and his al Qaeda
network may have radioactive weapons in their possession, The New York
Times reported on Friday.
- So far the drug, a steroid hormone known as
that appears to strengthen the immune system, has been tested as a
protectant only in mice, the newspaper said in its online edition.
- In one test, an injection protected 70 percent of mice
from a level of radiation that killed all the mice in the control group,
- The drug is receiving increased scrutiny along with other
experimental treatments and drugs already on the market as fears of terror
attacks grow, the newspaper said. The National Cancer Institute, the
of Defense and the Department of Energy have invited radiation experts
to a two-day workshop starting Dec. 17 in Bethesda, Maryland to review
approaches for protecting people from radiation, The New York Times
- Rights to 5-androstenediol are held by San Diego-based
Hollis-Eden Pharmaceuticals Inc., the newspaper added.
Site Served by TheHostPros